Efficiency of Cytokine-Induced Killer Cells in Combination with Chemotherapy for Triple-Negative Breast Cancer.

Conclusion: The data suggested that CIK cell immunotherapy improved the efficiency of regular chemotherapy in patients with TNBC, and the side effects of CIK cell immunotherapy were mild. PMID: 29963110 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/29963110?dopt=Abstract

Source: Journal of Breast Cancer - July 4, 2018 Category: Cancer & Oncology Tags: J Breast Cancer Source Type: research